Surging Cancer Prevalence Driving Aspiration and Biopsy Needles Market Growth
A number of factors such as the increasing cases of cancer, mounting healthcare expenditure, surging awareness regarding cancer and cancer treatment options, soaring preference for minimally invasive surgeries, and rising technological advancements in image-guided biopsy systems are expected to drive the aspiration and biopsy needles market at a CAGR of 7.2% during the forecast period (2020–2030). According to P&S Intelligence, the market revenue stood at $801.5 million in 2019 and it is projected to reach $1,717.9 million by 2030. The aspiration and biopsy needles market is being driven by the surging cases of cancers across the world. According to the World Health Organization (WHO), in 2020, cancer accounted for approximately 10 million deaths. Breast, lung, colon and rectum, prostate, skin (non-melanoma), and stomach cancers were the most prevalent types of cancer in 2020. Different types of cancer are detected by biopsy and aspiration, which evaluates the nature of tumor by ta...